Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findings.
BACKGROUND
Multiple sclerosis (MS) occurs in young adults and infrequently appears in childhood.


OBJECTIVE
To determine the incidence of MS and describe the clinical, cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) findings at onset of MS in children in Israel.


METHODS
Incidence and case-specific data were obtained through the MS Center Database and Israeli Health Statistics Census Data over 15 years, from 1995 to 2009, and compared between patients with childhood (< 12 years), juvenile (> or = 12 years, < or = 18 years) and adult (> 18 years) MS onset.


RESULTS
Of 1129 eligible MS patients, we identified 10 (0.89%) with childhood-onset MS, 74 (6.55%) with juvenile-onset MS, and 1045 (92.56%) with adult-onset MS. There were 0 to 3 incident childhood cases/year, leading to an annual incidence of 0.1/100,000 among Israeli children; the incidence of juvenile and adult MS was 2.6 and 5.4/100,000, respectively. Neurological presentation among children with MS was optic neuritis, motor weakness or brainstem involvement. CSF oligoclonal immunoglobulin (IgG) were positive in 62.5%. The most frequent MRI finding was the occurrence of > or = 3 periventricular white matter lesions followed by corpus callosum lesions, with 71% co-occurrence. Cervical and thoracic lesions occurred in 33% and 43%, respectively. Time to second neurological event ranged from 0.3 to 4.2 years and none of the patients with childhood MS reached EDSS = 6.0 within a mean follow-up period of 8.4 years.


CONCLUSIONS
Childhood-onset MS is rare, with an incidence of 0.1/100,000 Israeli children. Childhood MS does not differ significantly from juvenile and adult-onset MS in terms of clinical, laboratory and imaging findings.
Multiple Sclerosis Center, Petah Tikva, Israel. Anat.Achiron@sheba.health.gov.il
Anat
A
Achiron
Ben-Zion
BZ
Garty
Shay
S
Menascu
David
D
Magalashvili
Mark
M
Dolev
Bruria
B
Ben-Zeev
Orit
O
Pinhas-Hamiel
D000293:Adolescent; D000328:Adult; D001921:Brain / Q000473:pathology; D002648:Child; D004172:Diplopia / Q000453:epidemiology / Q000209:etiology; D005071:Evoked Potentials; D005221:Fatigue / Q000453:epidemiology / Q000209:etiology; D005260:Female; D005334:Fever / Q000453:epidemiology / Q000209:etiology; D006261:Headache / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D007557:Israel / Q000453:epidemiology; D007964:Leukocytosis / Q000453:epidemiology / Q000209:etiology; D008279:Magnetic Resonance Imaging; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000453:epidemiology*; D018908:Muscle Weakness / Q000453:epidemiology / Q000209:etiology; D009759:Nystagmus, Pathologic / Q000453:epidemiology / Q000209:etiology; D043025:Oligoclonal Bands / Q000134:cerebrospinal fluid; D009902:Optic Neuritis / Q000453:epidemiology / Q000209:etiology; D012042:Registries; D013131:Spine / Q000473:pathology; D014839:Vomiting / Q000453:epidemiology / Q000209:etiology
D043025:Oligoclonal Bands